Alex Janin

New York

Health Reporter at The Wall Street Journal

Health reporter with a sweet tooth. @WSJ covering longevity and preventive care

Articles

Want Better Health and Status? For $250,000, Longevity Clinics Promise Both

2 weeks ago | wsj.com | Alex Janin

Forget social clubs and extravagant dinners. The health-conscious elite are flocking to high-end clinics in the hopes of getting ahead of the aging process. Alex Janin | Photographs by Jonah Rosenberg for WSJ For up to six figures a year, longevity clinics promise to buy their patrons longer, healthier lives. For now, they’re conferring something maybe just as valuable: status. Plenty of people are deciding the hefty fees are worth it.
Ozempic’s New Frontier: The War on Aging

1 month ago | tovima.com | Alex Janin

Research suggests benefits beyond what popular diabetes and weight-loss drugs were first approved to treatFor decades, scientists have been on the hunt for an antiaging drug. Now, some say we may have already found it. A fast-growing body of research signals potential health benefits of GLP-1s, the class of diabetes and weight-loss drugs known by names like Ozempic, beyond what they were initially approved to treat.
减肥“神药”诺和泰的潜在新用途：抗衰老

1 month ago | cn.wsj.com | Alex Janin

几十年来，科学家们一直在寻找抗衰老药物。现在有人说，我们可能已经找到了。越来越多的研究表明，GLP-1类药物（比如诺和泰(Ozempic) 等糖尿病和减肥药物）在最初获批的治疗范围之外或许还能带来其他健康益处，包括对抗与衰老相关的疾病，如阿尔茨海默病、骨关节炎、某些癌症，甚至死亡。Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Ozempic’s New Frontier: The War on Aging

1 month ago | wsj.com | Alex Janin

March 10, 2025 9:00 pm ETFor decades, scientists have been on the hunt for an antiaging drug. Now, some say we may have already found it. A fast-growing body of research signals potential health benefits of GLP-1s, the class of diabetes and weight-loss drugs known by names like Ozempic, beyond what they were initially approved to treat. That includes age-related conditions like Alzheimer’s, osteoarthritis, certain cancers and even mortality. Copyright ©2025 Dow Jones & Company, Inc.
広がるレッドライト治療、効果は？

1 month ago | jp.wsj.com | Alex Janin

健康に関心を持つ人々に「レッドライト治療」が受け入れられつつある。ただ役に立つかどうかを判断するのはまだ早い。　レッドライト治療とは、低レベルの赤色光または近赤外光を体に照射する、フォトバイオモジュレーションと呼ばれる光治療の一種で、体重を減らしたり、外見を若くしたり、気分を安定させたりするのに役立つとされている。ホテルのスパから欧州ではハチの巣箱にまで、あらゆるところに登場しつつある。Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Red Light Therapy Gets the Green Light, Sort Of

1 month ago | wsj.com | Alex Janin

Red-light therapy is getting the green light in some health circles, but it’s early yet to say whether that’s a good thing. The treatment, a type of light therapy called photobiomodulation that involves exposing the body to low levels of red or near-infrared light, purports to help users lose weight, look younger and balance mood. It’s popping up everywhere from hotel spas to European beehives.
老化は病気？科学者が論争

2 months ago | jp.wsj.com | Alex Janin

老化を病気に分類したい科学者が、数こそ少ないものの増えつつある。ただし分は悪い。　老化の仕組みの科学的な解明が進んだことで、一部の科学者や医師、起業家が「老化は病気」と主張し始めている。こうした人々によれば、老化は病気や死亡の主な促進要因で、老化を病気に分類すれば、老化が関係した健康問題だけでなく、老化そのものを治療するための医薬品が承認されやすくなる可能性があるという。Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
The Scientific Fight Over Whether Aging Is a Disease

2 months ago | msn.com | Alex Janin

Continue reading More for You Continue reading More for You
Trump’s Health Picks Take Longevity Movement Mainstream

Jan 15, 2025 | msn.com | Alex Janin

Continue reading More for You Continue reading More for You
Want to Lose Weight This Year? Start With What You Drink

Jan 1, 2025 | wsj.com | Alex Janin

Your health is more than just a number on a scale. But if losing a little weight is a New Year goal, skip fad diets and hard-to-maintain fitness resolutions. Instead, nutrition experts recommend something simpler: Don’t drink your calories. $13.75/Week $1.75/Week Includes unlimited digital access to The Wall Street Journal, MarketWatch, Barron’s and Investor’s Business Daily $9.75/Week $1/Week Includes unlimited digital access to WSJ's unrivaled journalism.